Back to Journals » Drug Design, Development and Therapy » Volume 9

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Total article views   HTML views PDF downloads Totals
18,605 Dovepress* 14,194+ 2,163 16,357
PubMed Central* 4,411 1,436 5,847
Totals 18,605 3,599 22,204
*Since 7 January 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar